Cargando…

Boehringer Ingelheim and Eli Lilly and Company announces trategic alliance to bring new diabetes treatments to patients worldwide

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Clinics Cardive Publishing 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6053646/
https://www.ncbi.nlm.nih.gov/pubmed/21298208
_version_ 1783340867586621440
collection PubMed
description
format Online
Article
Text
id pubmed-6053646
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Clinics Cardive Publishing
record_format MEDLINE/PubMed
spelling pubmed-60536462018-08-08 Boehringer Ingelheim and Eli Lilly and Company announces trategic alliance to bring new diabetes treatments to patients worldwide Cardiovasc J Afr Cardiovascular Topics Clinics Cardive Publishing 2011 /pmc/articles/PMC6053646/ /pubmed/21298208 Text en Copyright © 2015 Clinics Cardive Publishing http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Cardiovascular Topics
Boehringer Ingelheim and Eli Lilly and Company announces trategic alliance to bring new diabetes treatments to patients worldwide
title Boehringer Ingelheim and Eli Lilly and Company announces trategic alliance to bring new diabetes treatments to patients worldwide
title_full Boehringer Ingelheim and Eli Lilly and Company announces trategic alliance to bring new diabetes treatments to patients worldwide
title_fullStr Boehringer Ingelheim and Eli Lilly and Company announces trategic alliance to bring new diabetes treatments to patients worldwide
title_full_unstemmed Boehringer Ingelheim and Eli Lilly and Company announces trategic alliance to bring new diabetes treatments to patients worldwide
title_short Boehringer Ingelheim and Eli Lilly and Company announces trategic alliance to bring new diabetes treatments to patients worldwide
title_sort boehringer ingelheim and eli lilly and company announces trategic alliance to bring new diabetes treatments to patients worldwide
topic Cardiovascular Topics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6053646/
https://www.ncbi.nlm.nih.gov/pubmed/21298208